Key result
Plasmapheresis drives recovery in ~92% of heart transplant humoral rejection cases diagnosed by C4d testing.
Why the study?
Severe allograft dysfunction after heart transplant without ischemia or cellular rejection is rare and its incidence, diagnosis, and management remain uncertain.
Observational (n=445)
Humoral rejection is a rare (<3%) complication after heart transplantation that responds well to plasmapheresis, and C4d staining is a useful diagnostic marker.
Answers are grounded in this paper and cite their sources.
HR diagnosis in HT warrants caution with conventional criteria alone; leaves open optimal immunopathologic standards for future validation.
Severe allograft dysfunction after heart transplant (HT), without ischemia or evidence of cellular rejection upon endomyocardial biopsy (EMB), is a rare but potentially fatal condition that suggests humoral rejection (HR). Its incidence, and the methods of choice for its diagnosis and management, remain uncertain. We retrospectively studied 445 HT patients (April 1991-December 2003) to determine incidence of HR diagnosed by clinical and conventional histopathological criteria. We used immunofluorescence (IF) techniques to test archived frozen EMB issue for IgM, IgG, C1q, C3, fibrin and C4d. Twelve patients (2.7%) fulfilled the criteria for HR after a mean time post-HT of 21.3 +/- 24.7 months (range: 2-72 months). Patients were treated with high doses of steroids and plasmapheresis, with successful recovery in 11 cases. IF studies using classical markers were mainly negative for the six patients with enough EMB tissue for testing. All six patients showed positivity for C4d during the HR episode but not before or after. Humoral rejection was observed in less than 3% of HT patients. Plasmapheresis treatment was highly effective. Classical IF tests were not useful for diagnosis, but C4d appears to be useful both for confirmation of diagnosis and for monitoring response to treatment.
No takes yet. Share an insight, caveat, or question.
Crespo‐Leiro et al. (2005) conducted an observational in Heart transplant (n=445). Humoral rejection was evaluated on Incidence of humoral rejection. Humoral rejection was observed in 2.7% of heart transplant patients, with C4d testing proving useful for diagnosis and plasmapheresis resulting in successful recovery in 11 of 12 cases.
Synapse has enriched 10 related papers. Consider them for comparative context: